Patient YML ABPA and mucoid impaction Image 1

ABPA and mucoid impaction

Date: 8 January 2016

  • Patient YML ABPA and mucoid impaction Image 1

  • Patient YML ABPA and mucoid impaction Image 2

Prev
Next

Copyright: n/a

Notes:

74 year old woman, known to have ABPA without asthma, bronchiectasis and oesophagitis and reflux. Presented originally age 68 years and improved with itraconazole. This was stopped and she continued on daily hypertonic saline nebulisers, with continuing cough. 
 
Relapsed with chronic cough and increasing breathlessness. She had a trachea deviated to the left and silent breath sounds in the left upper zone and left base. A bronchoscopy showed mucoid impaction and complete occlusion of the left upper and left lower lobes with thick mucus. This was removed with saline and suction, and distally the airways were normal. Her total and Aspergillus specific IgE had risen from 1100 kU/L and 13.0 kAU/L in August 2015 to 5100 kU/l and 21.6 kAU/L in November 2015. Her Aspergillus IgG also rose from 44mg/L to 102 mg/L over the same period.
 
She continued on prednisolone and itraconazole was restarted. She improved and her chest Xray abnormalities resolved.
 

Images library

Showing 10 posts of 2574 posts found.

  • Title

    Legend

  • Papular rash with CPA

    Drug rashes: Drug interactions between steroids and anti-fungal drugs – (ecchymosis)

    Image A: Red skin rash on arms due to effect of inhaled steroids termed ecchymosis., Image B: Red skin rash on arms due to effect of inhaled steroids termed ecchymosis., Image C: Papular rash with blisters on the back, associated with CPA but prior to treatment, rash appeared 2 years previously in October 2007. The rash resolved on treatment with azoles., Image D: Papular rash with blisters on the back, associated with CPA but prior to treatment, rash appeared 2 years previously in October 2007. The rash resolved on treatment with azoles.

  • Facial erythema: Side effects of anti-fungal drugs – drug rashes

    Reference: Muco-cutaneous retinoid effects and facial erythema related to the novel triazole antifungal agent voriconazole. Denning, DW & Griffiths, CEM. Clin.Exp Dermatol 2001, 26(8), 648-53.
    Courtesy of Dr D Denning, Wythenshawe Hospital, Manchester.(© Fungal Research Trust)

    Patient AB: Voriconazole rash. Following 8 weeks of Voriconazole, patient had remarkable facial erythema, most consistent with sun exposure because of sparing of her neck., Patient AB: Voriconazole rash. Following 8 weeks of Voriconazole, patient had remarkable facial erythema, most consistent with sun exposure because of sparing of her neck., Patient AB: Discoid lupus erythematosus following 12 months voriconazole therapy. This improved with use of sunblock factor 30 and resolved after discontinuation of voriconazole, 2 months later.

  • Cresemba

    Cresemba (Isavuconazole)

  • Germinating spores of Aspergillus fumigatus

    Germinating spores of Aspergillus fumigatus

  • Aspergillus niger

    Micrographs of A. niger conidia & conidial heads provided by Amaliya Stepanova, Head of Laboratory pathomorphology and cytology at Kashkin Research Institute, Russian Federation.

    A niger conidial head TEM in vitro (РКПГF-1124), A niger mature conidium TEM in vitro (РКПГF-1124)

  • Aspergillus terreus

    Micrographs of A. terreus conidia & conidial heads provided by Amaliya Stepanova, , Head of Laboratory pathomorphology and cytology at Kashkin Research Institute, Russian Federation.

    A terreus aleurospore TEM in vitro (РКПГF-1275), A terreus mature conidium SEM in vitro (РКПГ-1275), A terreus mature conidial head SEM in vitro

  • Electron Microscopy: Aspergillus fumigatus

    Micrographs of A. fumigatus conidia & conidial heads provided by Amaliya Stepanova, , Head of Laboratory pathomorphology and cytology at Kashkin Research Institute, Russian Federation.

    Conidial head (SEM), Part of conidial head (SEM), Mature conidia (SEM), Hyphae (SEM), Murine lung tissue (TEM)

  • Aspergillus clavatus

    Isolate from environmental sample

    A. clavatus, A. clavatus, A. clavatus

  • ABPA complicated by severe varicose bronchiectasis

    Patients has history of ABPA complicating long standing asthma. His total IgE has fluctuated between 2,200 and 4,600 KU/L, his Aspergillus IgE between 36.3 and 65.4 kAU/L and Aspergillus IgG from 87-154 mg/L. He has been taking long term itraconazole.

    December 2012, May 2012, AW CT Dec 2012 2, February 2010

  • Ira F. Salkin 1941-2016

    Ira F. Salkin 1941-2016